| | | | | |
ANIK Anika Therapeutics Inc | $21,3900 | +0,23 % | $294,82M | $5,000 | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4850 | -0,24 % | $294,73M | $7,10K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0400 | -0,10 % | $294,68M | $14,28K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,5100 | +0,14 % | $294,53M | $512,00 | |
| $43,3300 | -0,05 % | $294,35M | $91,00 | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $9,9900 | -0,10 % | $294,35M | $36,00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00 % | $294,33M | $815,00 | |
SLN Silence Therapeutics Plc American Depository Share | $13,1850 | +0,11 % | $294,27M | $65,00 | |
MTNE CH4 Natural Solutions Corporation | $9,8950 | +0,05 % | $293,88M | $7,000 | |
RXST RxSight, Inc. Common Stock | $6,0950 | +0,08 % | $293,64M | $2,54K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6200 | +0,09 % | $293,52M | $581,11K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,00 % | $293,49M | $639,00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9,3750 | -0,58 % | $293,27M | $96,00 | |
| $10,6500 | +0,57 % | $292,98M | $13,33K | |
JCE Nuveen Core Equity Alpha Fund | $16,9700 | +0,00 % | $292,78M | $15,74K | |
